Status:
COMPLETED
Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic
Lead Sponsor:
University Hospital, Rouen
Conditions:
COVID
RT-ddPCR Multiplex
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the study is to develop and validate a molecular diagnostic strategy (RT-ddPCR multiplex) of COVID-19 based on a saliva sample and alternative to the RT-qPCR method, in order to : 1....
Eligibility Criteria
Inclusion
- Person aged over 18 years presenting to the COVID-19 consultation of the Rouen University Hospital for screening
- Person affiliated to a social security scheme
Exclusion
- Person objecting to participation in the research after reading information
- Person under the protection of justice,
- Person deprived of their liberty by administrative or judicial decision (guardianship, curatorship, etc.)
- Patient under guardianship or curatorship
Key Trial Info
Start Date :
April 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 17 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04367545
Start Date
April 16 2020
End Date
May 17 2020
Last Update
November 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rouen University Hospital
Rouen, France